April 2 (Reuters) - Trillium Therapeutics Inc TRIL.TO :
* TRILLIUM THERAPEUTICS EXPANDS IMMUNO-ONCOLOGY PIPELINE WITH STING AGONIST PROGRAM
April 2 (Reuters) - Trillium Therapeutics Inc TRIL.TO :
* TRILLIUM THERAPEUTICS EXPANDS IMMUNO-ONCOLOGY PIPELINE WITH STING AGONIST PROGRAM